Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.

Kalman La, Kris Mg, Gralla Rj, Kelsen Dp, Casper Es, Heelan Rt, Wittes Re, Leonard A Kalman

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalCancer treatment reports
Volume67
StatePublished - Jun 1 1983

Disciplines

  • Medicine and Health Sciences
  • Oncology

Cite this